This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Foot Locker (FL) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Foot Locker (FL) closed at $61.20 in the latest trading session, marking a +0.99% move from the prior day.
Top-Ranked Value ETFs & Stocks You'll be a Fool to Ignore
by Sanghamitra Saha
Real bargains lie in the value spectrum of the market. Given the host of uncertainty in the broader market, investors can buy these top-ranked value ETFs and stocks.
Reasons Behind Tapestry's (TPR) Sluggish Run on the Bourses
by Zacks Equity Research
Tapestry's (TPR) SG&A expenses have been increasing for quite some time now.
5 High-Yielding Stocks for an Uncertain April
by Nalak Das
The first-quarter 2019 performance does not guarantee continued success.
Foot Locker (FL) Up 1.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Foot Locker (FL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured expert Kevin Matras highlights: Medifast, Foot Locker, Comfort Systems, EMCOR and Robert Half International
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Medifast, Foot Locker, Comfort Systems, EMCOR and Robert Half International
Depend on DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than a simple ROE calculation? Invest in these five best bets then.
Do Options Traders Know Something About Foot Locker (FL) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Foot Locker (FL) stock based on the movements in the options market lately.
Shoe Carnival (SCVL) Q4 Earnings & Sales Surpass Estimates
by Zacks Equity Research
Shoe Carnival's (SCVL) top and bottom lines surpass the Zacks Consensus Estimate in the fourth quarter of fiscal 2018. Also, the company retained its fiscal 2019 view.
Companhia Brasileira Up 16% in 3 Months: Will Momentum Stay?
by Zacks Equity Research
Companhia Brasileira (CBD) is gaining from the Assai unit, Pilot Projects and strategy for 2018-2020.
The Zacks Analyst Blog Highlights: RH, Foot Locker, Quanta, Celgene and CBRE
by Zacks Equity Research
The Zacks Analyst Blog Highlights: RH, Foot Locker, Quanta, Celgene and CBRE
Pick These 5 Retail Stocks to Craft a Standout Portfolio
by Zacks Equity Research
Fears of a possible recession, given the yield-curve inversion, gripped the stock market lately. Some experts still believe that the U.S. economy remains fundamentally sound given strong labor market.
Ascena (ASNA) Surges: Stock Moves 8.4% Higher
by Zacks Equity Research
Ascena (ASNA) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Fossil Down 42% in 6 Months: Is There Room for Recovery?
by Zacks Equity Research
Fossil (FOSL) is struggling with soft sales, owing to persistent sluggishness in the traditional watches, and leather and jewelry businesses.
What's Next for Nike Stock & Why Lululemon (LULU) is a Buy Before Q4 Earnings
by Benjamin Rains
Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research where Associate Stock Strategist Ben Rains breaks down Nike's (NKE) Q3 fiscal 2019 financial results that led to a small selloff on the back of lower-than-expected sales in a key business. The episode then dives into what to expect from Lululemon's (LULU) Q4 earnings.
5 Value Picks to Counter Yield Inversion of Government Bonds
by Nalak Das
The yield inversion was mainly caused by the Fed's extra dovish monetary stance, which triggered investors' concerns about a global economic slowdown.
Has Foot Locker (FL) Outpaced Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Is (FL) Outperforming Other Retail-Wholesale Stocks This Year?
Are Investors Undervaluing Foot Locker (FL) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tiffany's (TIF) Q4 Earnings Meet, Revenues Miss, Stock Down
by Zacks Equity Research
Tiffany's (TIF) results were impacted by reduced sales to foreign tourists and lower demand from local customers across most regions and product categories.
Children's Place Announces 12% Hike in Quarterly Dividend
by Zacks Equity Research
Children's Place (PLCE) increases the quarterly dividend by 12%, marking the fifth consecutive quarter of dividend increase.
Breaking Down Nike's (NKE) Q3 Earnings: North America, China & More
by Benjamin Rains
Nike (NKE) posted better-than-expected Q3 fiscal 2019 earnings and revenue after the closing bell Thursday. So, let's break down the sportswear giant's footwear sales, as well as North American and Chinese revenue.
Here's Why Nike (NKE) Stock Looks like a Buy Heading into Q3 Earnings
by Benjamin Rains
Heading into its Q3 fiscal 2019 earnings report, which is due out after the closing bell Thursday, Nike is a Zacks Rank #2 (Buy). So, let's see what to expect from the company's third quarter financial results, including North American and Chinese sales.
Foot Locker, Urban Outfitters, FedEx and United Parcel highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Foot Locker, Urban Outfitters, FedEx and United Parcel highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Foot Locker, Inc. (FL)
by Benjamin Rains
Shares of Foot Locker (FL) have climbed 14% this year to outpace the S&P 500 and its industry's 9% average climb. The sneaker-focused sporting goods retailer is also coming off a better-than-expected quarter and looks poised to expand its bottom line as it invests in the future of its industry.
Bear of the Day: Urban Outfitters, Inc. (URBN)
by Benjamin Rains
Shares of Urban Outfitters, Inc. (URBN) have plummeted 30% over the last six months and its earnings estimate revision activity has tumbled in the wrong direction, especially in the near-term, on the back of lower-than-expected Q1 guidance.